Stankovich Thomas

Chief Financial OfficerReShape Lifesciences Inc. (RSLS) · full profile →Form 4 · filed Jun 1, 2022
Net Buying
Open-Market Buys
$18K
Open-Market Sells
$0
Net Open-Market Flow
$18K
Transactions
8
8 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 31, 2022Buy(P)1K$0.95$1K366K
May 31, 2022Buy(P)7K$0.94$6K364K
May 31, 2022Buy(P)60$0.93$56358K
May 31, 2022Buy(P)8K$0.92$7K358K
May 31, 2022Buy(P)1K$0.90$900350K
May 31, 2022Buy(P)200$0.89$178349K
May 31, 2022Buy(P)3K$0.88$3K349K
May 31, 2022Buy(P)78$0.87$68346K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-067045) within minutes of acceptance. Every field above traces to the original document. Verify it directly: